Running
← Markets

ABT$109.70

Position
1 sh
avg $110.12 · now $109.70
Unrealized
−$0.41
−0.38%
Realized P&L
$0.00
0 wins · 0 losses
Decisions
1
1 fills · 0 open options
Price & the bot's trades
Regular-session prices. Markers sit at the actual fill price; hover a bar for the details.
Price▲ buy · ▼ sell (paper fills) Stop / target

Nov 11, 9:30 AM to Nov 11, 3:35 PM: from $109.27 to $109.86, low $109.27, high $110.20. 1 buy and 0 sells marked.

Current plan · Multi Day · Breakout · stop $109.10 · target $115.00 · value $109.71

ABT broke above its 15-min opening range high (110.04) on 2.2× median volume, closing at 110.17. The move is supported by a T2 catalyst: FDA approval and CE Mark for a new implantable cardioverter-defibrillator lead (Nov 11, 6:33 AM ET). Technically, ABT is in a strong uptrend (above SMA20/50/200) with RSI 58.4 and room to the 52-week high (132.03). The opening range low (109.1) provides a natural stop. Target 115.0 offers ~4.4% upside vs ~1% risk.

Invalidation: Price closes below 109.1 (opening range low) or news reverses the FDA approval narrative.

Trades

FilledSymbolSideTypeQtyPriceValueRealized P&LWhy
Nov 11, 1:02 PM ETABTbuyEntry1$110.12$110.12—ABT broke above its 15-min opening range high (110.04) on 2.2× median volume, closing at 110.17. The move is supported by a T2 catalyst: FDA approval and CE Mark for a new implantable cardioverter-defibrillator lead (Nov 11, 6:33 AM ET). Technically, ABT is in a strong uptrend (above SMA20/50/200) with RSI 58.4 and room to the 52-week high (132.03). The opening range low (109.1) provides a natural stop. Target 115.0 offers ~4.4% upside vs ~1% risk.

Decisions

TimeSymbolActionConv.RationaleResult
Nov 11, 1:02 PM ETABTbuy8/10

ABT broke above its 15-min opening range high (110.04) on 2.2× median volume, closing at 110.17. The move is supported by a T2 catalyst: FDA approval and CE Mark for a new implantable cardioverter-defibrillator lead (Nov 11, 6:33 AM ET). Technically, ABT is in a strong uptrend (above SMA20/50/200) with RSI 58.4 and room to the 52-week high (132.03). The opening range low (109.1) provides a natural stop. Target 115.0 offers ~4.4% upside vs ~1% risk.

1 sh @ $110.12 ($110.12) · stop $109.10 · target $115.00

Executedbought 1 shares